Page last updated: 2024-09-04

ivabradine and MODS

ivabradine has been researched along with MODS in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebelt, H; Müller-Werdan, U; Nuding, S; Presek, P; Schröder, J; Werdan, K; Wienke, A1
De Santis, V; Frati, G; Greco, E; Tritapepe, L1
Ebelt, H; Hoke, RS; Krummenerl, A; Müller-Werdan, U; Nuding, S; Werdan, K; Wienke, A1

Trials

2 trial(s) available for ivabradine and MODS

ArticleYear
Reducing Elevated Heart Rates in Patients with Multiple Organ Dysfunction Syndrome with The If (Funny Channel Current) Inhibitor Ivabradine.
    Shock (Augusta, Ga.), 2018, Volume: 49, Issue:4

    Topics: Adrenergic beta-Antagonists; Aged; Cardiovascular Agents; Female; Heart Rate; Hemodynamics; Humans; Ivabradine; Middle Aged; Multiple Organ Failure

2018
Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2011, Volume: 100, Issue:10

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Benzazepines; Contraindications; Critical Illness; Cyclic Nucleotide-Gated Cation Channels; Female; Germany; Heart Conduction System; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Middle Aged; Multiple Organ Failure; Patient Selection; Potassium Channels; Prospective Studies; Research Design; Time Factors; Treatment Outcome

2011

Other Studies

1 other study(ies) available for ivabradine and MODS

ArticleYear
Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:10

    Topics: Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Treatment Outcome

2014